CancerRadar scans newly published research and translates important findings into plain language.
Today's insight
23 Apr
New research explores if acupuncture can ease nausea in breast cancer patients undergoing chemo. Studies show promising results, but more analysis is needed to pinpoint the most effective methods. Learn more about this ongoing study on our research page: Acupuncture for Nausea...
Phase 1/2 TrialCombined safety and early effectiveness trial in humans.Lung CancerPublished: April 21, 2026
Amivantamab Shows Promise in Treating Advanced Colorectal Cancer
Researchers tested a new treatment called amivantamab in people with advanced colorectal cancer that didn't respond to other treatments. They found that amivantamab seemed to slow the growth of tumors in some patients, but more research is needed to confirm these results.
Why it matters: This finding could lead to new treatment options for people with advanced colorectal cancer who have run out of other choices.
Efficacy
The overall response rate was 29% in left-sided cohorts, and 22% in the right-sided cohort.
Lab StudyLaboratory experiments on cells or tissue. No human or animal data.Lung CancerPublished: April 21, 2026
Combining Colchicine and Rosiglitazone May Help Treat Lung Cancer
Researchers tested a combination of two drugs, colchicine and rosiglitazone, to see if it could help treat non-small cell lung cancer. They found that in some lab experiments, this combination worked better than either drug alone, but the results were different depending on the type of cancer cell. The study suggests that this combination may be a promising area for further research.
Why it matters: This finding could lead to new treatment options for patients with non-small cell lung cancer, particularly those with certain genetic mutationsA change in DNA sequence that can drive cancer development.Click for full explanation →.
The study was conducted in lab experiments using two specific types of lung cancer cells, and the results may not apply to all patients with non-small cell lung cancer.
Observational StudyPatterns observed in populations over time, not a controlled experiment.Breast CancerPublished: April 21, 2026
ChemotherapyDrugs that kill rapidly dividing cells, including cancer cells.Click for full explanation → dose intensity and neutropenia in early breast cancer
Researchers studied how chemotherapyDrugs that kill rapidly dividing cells, including cancer cells.Click for full explanation → dose intensity affects outcomes in early breast cancer patients. They found that patients who received reduced chemotherapyDrugs that kill rapidly dividing cells, including cancer cells.Click for full explanation → dose intensity without neutropenia had poorer outcomes, but those with neutropenia showed no significant difference in survival. These findings are preliminary and require further confirmation.
Why it matters: This study's findings may help guide treatment decisions for early breast cancer patients.
Observational StudyPatterns observed in populations over time, not a controlled experiment.Breast CancerPublished: April 21, 2026
New Cancer Research Tool Shows Promise in Predicting Breast Cancer Outcomes
Researchers compared different methods for predicting breast cancer survival using data from over 780 patients. They found that some newer methods were better at predicting survival than older methods. However, the results are based on a single study and need further validation.
Why it matters: This finding could help doctors better understand breast cancer and make more accurate predictions about patient outcomes.
✦ Significant findingA meaningful signal from later-stage research, or a strong phase 2 result that stands out from routine findings.Meta-AnalysisStatistical pooling of results from multiple studies.Breast CancerPublished: April 21, 2026
Acupuncture for Breast Cancer Nausea Relief
Researchers are studying whether acupuncture can help reduce nausea and vomiting in breast cancer patients undergoing chemotherapyDrugs that kill rapidly dividing cells, including cancer cells.Click for full explanation →. They will analyze data from multiple studies to understand which acupuncture methods are most effective. The results will help clinicians choose the best acupuncture options for their patients.
Why it matters: This research aims to provide more evidence-based options for clinicians to treat chemotherapyDrugs that kill rapidly dividing cells, including cancer cells.Click for full explanation →-induced nausea and vomiting in breast cancer patients.
Lab StudyLaboratory experiments on cells or tissue. No human or animal data.Lung CancerPublished: April 21, 2026
KSR2 linked to resistance to cancer treatment
Researchers studied how cancer cells become resistant to a common treatment called anti-PD-1 therapy. They found that a protein called KSR2 might play a role in this resistance by changing how cancer cells use glucose. This could help explain why some cancer treatments don't work as well as they should.
Why it matters: This finding could help scientists understand why some cancer treatments don't work and identify new targets for treatment.
This study was conducted in a mouse model and may not directly apply to humans.
CancerRadar is a public research monitor. It scans peer-reviewed publications, clinical trial registries, and authoritative sources daily, then explains what is new and why it might matter, without overstating the evidence.
Every finding is linked to its original source. Evidence stages are labeled clearly: preclinical, trial phase, observational, or review-level. We do not diagnose, recommend treatment, or give medical advice.
